Loading clinical trials...
Loading clinical trials...
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is the new clinical term introduced in 2023 to redefine what was formerly known as Non-Alcoholic Fatty Liver Disease (NAFLD). It is def...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Fu Jen Catholic University Hospital
NCT02337894 · Liver Steatosis, Insulin Resistance, and more
NCT05946148 · Non-Alcoholic Fatty Liver Disease, Liver Steatosis
NCT05612334 · Liver Function Tests
NCT03957070 · Liver Fibrosis, Liver Steatosis
NCT04669470 · Obesity, NAFLD, and more
Fu Jen Catholic University Hospital
New Taipei City
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions